Clinical Trial Update: Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating whether Neupogen (filgrastim) can affect stroke recovery, sponsored by the Ottawa Hospital Research Institute; the cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Neupogen (Filgrastim)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Ischemic Stroke | Phase 1 | Status: UNKNOWN